Literature DB >> 2038208

Intravascular techniques for extraction of permanent pacemaker leads.

C L Byrd, S J Schwartz, N Hedin.   

Abstract

Intravascular techniques were used to extract 226 leads from 124 patients. Indications for lead extraction were life-threatening septicemia (30%), complications of free-floating leads (2%), abandonment of pockets (40%), and replacement of malfunctioning leads (28%). Extraction tools included flexible, telescoping sheaths advanced over the lead to dilate scar tissue and apply countertraction, deflection catheters, and wire basket snares. Countertraction is defined as the direct force of traction on the lead countered by the circumference of an extraction sheath. One hundred sixty-four leads were extracted through the superior vena cava by advancing the sheaths over the lead to the myocardial wall. Most of these leads passed through the subclavian vein. An approach through the inferior vena cava was used for the remaining 62 leads. The countertraction sheaths were passed from the femoral vein into the right atrium. A maneuvering catheter and an extracting snare were placed inside the sheaths. The lead was positioned by the maneuvering catheter, entangled in the extracting snare, and the sheaths advanced over the snare and lead to the myocardium. An atriotomy by means of a limited surgical approach was required to free one lead. One infected lead broke 5 cm from the electrode and was removed through a median sternotomy, ventriculotomy, and retrograde extraction. All patients had unremarkable recoveries. Intravascular countertraction techniques proved to be a viable alternative, minimizing the risks and morbidity of lead removal.

Entities:  

Mesh:

Year:  1991        PMID: 2038208

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  12 in total

Review 1.  Advances in device lead extraction.

Authors:  C L Byrd
Journal:  Curr Cardiol Rep       Date:  2001-07       Impact factor: 2.931

2.  Minimally invasive removal of infected pacemaker lead.

Authors:  N Hirata; S Ohtake; Y Sawa; A Amemiya; S Asada; H Matsuda
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2000-08

3.  [Removal of retained transvenous pacemaker electrodes under cardiopulmonary bypass].

Authors:  T Kimura; Y Chiba; A Ihaya; T Tsuda; H Sasaki; R Muraoka
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1998-03

4.  [Removal of the endocardial pacemaker leads--experience with 16 leads in 10 patients].

Authors:  S Hasegawa; T Morimoto; N Matsuyama; J Okamoto; Y Sawada; K Kondo; K Asada; S Sasaki
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1998-05

5.  Extraction of permanent pacing leads: there are still controversies.

Authors:  D L Hayes
Journal:  Heart       Date:  1996-06       Impact factor: 5.994

Review 6.  Transvenous Lead Extractions: Current Approaches and Future Trends.

Authors:  Adryan A Perez; Frank W Woo; Darren C Tsang; Roger G Carrillo
Journal:  Arrhythm Electrophysiol Rev       Date:  2018-08

Review 7.  Tricuspid valve repair for torrential tricuspid regurgitation after permanent pacemaker lead extraction.

Authors:  Deepak Mehrotra; Nand K Kejriwal
Journal:  Tex Heart Inst J       Date:  2011

8.  Sudden death under successful medical management of sick sinus syndrome after cardiac pacing discontinuation.

Authors:  Satoru Okumura; Masatoshi Kawata; Satoshi Niu; Koichi Ohga
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2002-10

9.  Is there an adverse outcome from abandoned pacing leads?

Authors:  C Suga; D L Hayes; L K Hyberger; M A Lloyd
Journal:  J Interv Card Electrophysiol       Date:  2000-10       Impact factor: 1.900

10.  Transvenous removal of pacing and implantable cardiac defibrillating leads using single sheath mechanical dilatation and multiple venous approaches: high success rate and safety in more than 2000 leads.

Authors:  Maria Grazia Bongiorni; Ezio Soldati; Giulio Zucchelli; Andrea Di Cori; Luca Segreti; Raffaele De Lucia; Gianluca Solarino; Alberto Balbarini; Mario Marzilli; Mario Mariani
Journal:  Eur Heart J       Date:  2008-10-23       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.